Browsing Molekulare Medizin by Advisor "Bayer, Thomas A. Prof. Dr."
Now showing items 1-3 of 3
-
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
(2016-04-14)Targeting Aβ has recently been the main objective in Alzheimer’s disease therapeutic approaches. Passive immunization trials have encountered undesirable side effects but the therapy remains a promising option. Aβ4-x has ... -
Impact of N-terminally truncated Aß4-42 on memory and synaptic plasticity - Tg4-42 a new mouse model of Alzheimer's disease
(2015-01-14)A heterogeneous mixture of amyloid beta (Aβ) variants exists in Alzheimer’s disease (AD) brains. So far, little is known how individual Aβ species contribute to development and progression of this neurodegenerative disorder. ... -
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
(2015-01-06)N-truncated Aβ4-42 has been identified as a particular abundant Aβ species in the hippocampus and cortex of Alzheimer's patients. However, relatively little is known about the contribution of Aβ4-42 to the development and ...